Editors' ChoiceMetabolism

Fetal against fatal: In utero genome editing to prevent metabolic disease

See allHide authors and affiliations

Science Translational Medicine  24 Oct 2018:
Vol. 10, Issue 464, eaav3892
DOI: 10.1126/scitranslmed.aav3892

Abstract

In utero CRISPR editing allows early intervention for inborn errors of metabolism in mice.

View Full Text

Stay Connected to Science Translational Medicine